Josie Germain Ford

6PUBLICATIONS
86CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 17, 2025
Real-world evidence of duvelisib and romidepsin in relapsed/refractory peripheral and cutaneous T-cell lymphomas.

Josie G Ford, Min Jung Koh, Alexandra W Lenart

|Oct 31, 2024
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium.

Jessy Xinyi Han, Min Jung Koh, Leora Boussi

|Jan 31, 2024
Real-world evidence of obinutuzumab and venetoclax in previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.

Matthew M Lei, Mark N Sorial, Uvette Lou

|Jan 22, 2024
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes.

Bimarzhan Assatova, Robert Willim, Christopher Trevisani

Pageof 1

Frequent Collaborators

3 joint publications

Salvia Jain

3 joint publications

Khyati Maulik Kariya

3 joint publications

Min Jung Koh

3 joint publications

Kusha Chopra